Modulation of the Arginase Pathway in the Context of Microbial Pathogenesis: A Metabolic Enzyme Moonlighting as an Immune Modulator
Arginine is a crucial amino acid that serves to modulate the cellular immune response during infection. Arginine is also a common substrate for both inducible nitric oxide synthase (iNOS) and arginase. The generation of nitric oxide from arginine is responsible for efficient immune response and cytotoxicity of host cells to kill the invading pathogens. On the other hand, the conversion of arginine to ornithine and urea via the arginase pathway can support the growth of bacterial and parasitic pathogens. The competition between iNOS and arginase for arginine can thus contribute to the outcome of several parasitic and bacterial infections. There are two isoforms of vertebrate arginase, both of which catalyze the conversion of arginine to ornithine and urea, but they differ with regard to tissue distribution and subcellular localization. In the case of infection with Mycobacterium, Leishmania, Trypanosoma, Helicobacter, Schistosoma, and Salmonella spp., arginase isoforms have been shown to modulate the pathology of infection by various means. Despite the existence of a considerable body of evidence about mammalian arginine metabolism and its role in immunology, the critical choice to divert the host arginine pool by pathogenic organisms as a survival strategy is still a mystery in infection biology.
Vyšlo v časopise:
Modulation of the Arginase Pathway in the Context of Microbial Pathogenesis: A Metabolic Enzyme Moonlighting as an Immune Modulator. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000899
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000899
Souhrn
Arginine is a crucial amino acid that serves to modulate the cellular immune response during infection. Arginine is also a common substrate for both inducible nitric oxide synthase (iNOS) and arginase. The generation of nitric oxide from arginine is responsible for efficient immune response and cytotoxicity of host cells to kill the invading pathogens. On the other hand, the conversion of arginine to ornithine and urea via the arginase pathway can support the growth of bacterial and parasitic pathogens. The competition between iNOS and arginase for arginine can thus contribute to the outcome of several parasitic and bacterial infections. There are two isoforms of vertebrate arginase, both of which catalyze the conversion of arginine to ornithine and urea, but they differ with regard to tissue distribution and subcellular localization. In the case of infection with Mycobacterium, Leishmania, Trypanosoma, Helicobacter, Schistosoma, and Salmonella spp., arginase isoforms have been shown to modulate the pathology of infection by various means. Despite the existence of a considerable body of evidence about mammalian arginine metabolism and its role in immunology, the critical choice to divert the host arginine pool by pathogenic organisms as a survival strategy is still a mystery in infection biology.
Zdroje
1. KosselA
DakinHD
1904 Über die Arginase. Z Physiol Chem 41 321 331
2. MoriM
2007 Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. J Nutr 137 1616S 1620S
3. WuG
MorrisSMJr
1998 Arginine metabolism: nitric oxide and beyond. Biochem J 336 (Pt1) 1 17
4. CederbaumSD
YuH
GrodyWW
KernRM
YooP
2004 Arginases I and II: do their functions overlap? Mol Genet Metab 81 Suppl 1 S38 44
5. McGeeDJ
RadcliffFJ
MendzGL
FerreroRL
MobleyHL
1999 Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity. J Bacteriol 181 7314 7322
6. McGeeDJ
ZabaletaJ
ViatorRJ
TestermanTL
OchoaAC
2004 Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J Biochem 271 1952 1962
7. BogdanC
2001 Nitric oxide and the regulation of gene expression. Trends Cell Biol 11 66 75
8. ChakravorttyD
HenselM
2003 Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 5 621 627
9. MunderM
EichmannK
MoranJM
CentenoF
SolerG
1999 Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163 3771 3777
10. ShearerJD
RichardsJR
MillsCD
CaldwellMD
1997 Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 272 E181 E190
11. VogiatziP
CassoneM
LuzziI
LucchettiC
OtvosLJr
2007 Helicobacter pylori as a class I carcinogen: physiopathology and management strategies. J Cell Biochem 102 264 273
12. GobertAP
McGeeDJ
AkhtarM
MendzGL
NewtonJC
2001 Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A 98 13844 13849
13. ChaturvediR
AsimM
LewisND
AlgoodHM
CoverTL
2007 L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 75 4305 4315
14. ZabaletaJ
McGeeDJ
ZeaAH
HernandezCP
RodriguezPC
2004 Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol 173 586 593
15. GobertAP
ChengY
WangJY
BoucherJL
IyerRK
2002 Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J Immunol 168 4692 4700
16. BussiereFI
ChaturvediR
ChengY
GobertAP
AsimM
2005 Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 280 2409 2412
17. LahiriA
DasP
ChakravorttyD
2008 Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect 10 1166 1174
18. TalaueMT
VenketaramanV
HazbonMH
Peteroy-KellyM
SethA
2006 Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection. J Bacteriol 188 4830 4840
19. El KasmiKC
QuallsJE
PesceJT
SmithAM
ThompsonRW
2008 Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 9 1399 1406
20. QuallsJE
DeFreitasA
SmithAM
WatowichSS
MurrayPJ
2009 Direct and indirect type-1 arginase (Arg1) induction following Mycobacterium bovis (BCG) infection. J Immunol 182 43.1
21. GiordanengoL
GuinazuN
StempinC
FretesR
CerbanF
2002 Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur J Immunol 32 1003 1011
22. AokiMP
GuinazuNL
PellegriniAV
GotohT
MasihDT
2004 Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes. Am J Physiol Cell Physiol 286 C206 C212
23. CuervoH
PinedaMA
AokiMP
GeaS
FresnoM
2008 Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J Infect Dis 197 1772 1782
24. NamangalaB
De BaetselierP
NoelW
BrysL
BeschinA
2001 Alternative versus classical macrophage activation during experimental African trypanosomosis. J Leukoc Biol 69 387 396
25. DuleuS
VincendeauP
CourtoisP
SemballaS
LagroyeI
2004 Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect. J Immunol 172 6298 6303
26. OzaSL
TetaudE
AriyanayagamMR
WarnonSS
FairlambAH
2002 A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi. J Biol Chem 277 35853 35861
27. ByersTL
BushTL
McCannPP
BitontiAJ
1991 Antitrypanosomal effects of polyamine biosynthesis inhibitors correlate with increases in Trypanosoma brucei brucei S-adenosyl-L-methionine. Biochem J 274 (Pt2) 527 533
28. GobertAP
DaulouedeS
LepoivreM
BoucherJL
BouteilleB
2000 L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect Immun 68 4653 4657
29. WanasenN
SoongL
2008 L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol Res 41 15 25
30. OsorioYE
ZhaoW
EspitiaC
TraviBL
HawelL
2008 Dominant arginase expression in a model of progressive visceral leishmaniasis. FASEB J 22 860.20
31. IniestaV
CarcelenJ
MolanoI
PeixotoPM
RedondoE
2005 Arginase I induction during Leishmania major infection mediates the development of disease. Infect Immun 73 6085 6090
32. KropfP
FuentesJM
FahnrichE
ArpaL
HerathS
2005 Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J 19 1000 1002
33. IniestaV
Gomez-NietoLC
CorralizaI
2001 The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med 193 777 784
34. RegueraRM
Balaña-FouceR
ShowalterM
HickersonS
BeverleySM
2009 Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol Biochem Parasitol 165 48 56
35. GaurU
RobertsSC
DalviRP
CorralizaI
UllmanB
2007 An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J Immunol 179 8446 8453
36. Scharton-KerstenTM
YapG
MagramJ
SherA
1997 Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185 1261 1273
37. SchluterD
Deckert-SchluterM
LorenzE
MeyerT
RollinghoffM
1999 Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. J Immunol 162 3512 3518
38. HesseM
ModolellM
La FlammeAC
SchitoM
FuentesJM
2001 Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167 6533 6544
39. AbdallahiOM
BensalemH
AugierR
DiaganaM
De ReggiM
2001 Arginase expression in peritoneal macrophages and increase in circulating polyamine levels in mice infected with Schistosoma mansoni. Cell Mol Life Sci 58 1350 1357
40. HarvieM
JordanTW
La FlammeAC
2007 Differential liver protein expression during schistosomiasis. Infect Immun 75 736 744
41. FitzpatrickJM
FuentesJM
ChalmersIW
WynnTA
ModolellM
2009 Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity. Int J Parasitol 39 267 279
42. GhoshS
NavarathnaDH
RobertsDD
CooperJT
AtkinAL
2009 Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. Infect Immun 77 1596 1605
43. CaoW
SunB
FeitelsonMA
WuT
Tur-KaspaR
2009 Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis. Int J Cancer 124 2886 2892
44. YoshiyamaH
NakazawaT
2000 Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect 2 55 60
45. RobertsSC
TancerMJ
PolinskyMR
GibsonKM
HebyO
2004 Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J Biol Chem 279 23668 23678
46. Shaked-MishanP
Suter-GrotemeyerM
Yoel-AlmagorT
HollandN
ZilbersteinD
2006 A novel high-affinity arginine transporter from the human parasitic protozoan Leishmania donovani. Mol Microbiol 60 30 38
47. HebyO
PerssonL
RentalaM
2007 Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids 33 359 366
48. BansalV
OchoaJB
2003 Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 6 223 228
49. WangCC
1991 A novel suicide inhibitor strategy for antiparasitic drug development. J Cell Biochem 45 49 53
50. GonzalezNS
HuberA
AlgranatiID
2001 Spermidine is essential for normal proliferation of trypanosomatid protozoa. FEBS Lett 508 323 326
51. MullerI
HailuA
ChoiBS
AbebeT
FuentesJM
2008 Age-related alteration of arginase activity impacts on severity of leishmaniasis. PLoS Negl Trop Dis 2 e235 doi:10.1371/journal.pntd.0000235
52. GrasemannH
SchwiertzR
MatthiesenS
RackeK
RatjenF
2005 Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 172 1523 1528
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection